Chlorhexidine Gluconate (CHG) Wipes Market

Chlorhexidine Gluconate Wipes Market Outlook (2023 to 2033)

The global chlorhexidine gluconate (CHG) wipes market is valued at US$ 44.6 billion in 2023 and is forecasted to reach US$ 67 billion by the end of 2033, expanding at a CAGR of 4% from 2023 to 2033.

Chlorhexidine gluconate wipes are effective in eradicating microorganisms and preventing wound infection. Several formulations and concentrations of chlorhexidine are available in the market. These wipes are commonly employed for cleaning the skin during hospital stays. 2% CHG wipes serve multiple purposes such as urological care, mouth care, and hand hygiene. These wipes have proven efficacy in reducing the likelihood of postoperative infections.

The CHG wipes market is segmented into various pharmacy distribution channels, such as hospital and retail pharmacies, as well as online platforms. Hospital and retail pharmacies are expected to dominate the chlorhexidine gluconate wipes market due to an increase in the number of post-operative and hospital-acquired infections. Rising prevalence of common hospital-acquired illnesses, such as surgical site infections (SSI) and catheter-associated urinary tract infections (CAUTI), is driving up the demand for chlorhexidine gluconate wipes.

CAUTI is one of the most prevalent hospital-acquired infections, and the risk of developing it increases with longer hospital stays. Demand for wipes and napkins specifically designed for urinary catheterization is projected to increase substantially over the forecast period.

• In September 2022, the Schülke Group, a well-known worldwide supplier of healthcare sanitation and infection control solutions, announced the acquisition of Vesismin Health, a Barcelona-based company specializing in hospital infection control.

Report Attributes	Details
Market Size in 2022	US$ 43.8 Billion
Estimated Market Value (2023)	US$ 44.6 Billion
Projected Market Value (2033)	US$ 67 Billion
Global Market Growth Rate (2023 to 2033)	4% CAGR
Australia Market Share in Asia Pacific (2023)	16.7%
North America Market Share (2023)	>1/3
Key Companies Profiled	Cardinal Health Pal International BD PDI Limited 3M Carenow Medical Pvt. Ltd. GAMA Healthcare Ltd. Lernapharm Inc. Becton Dickinson

How are Suppliers of CHG Wipes helping Reduce Surgery-related Infections?

“Increasing Collaborations between Suppliers and Pharmaceutical Formulation Experts Enhancing Efficacy of CHG Wipes”

To decrease infection during the process, the Centers for Disease Control and Prevention in the United States advise patients to shower preferably the night before surgery with chlorhexidine bath wipes. Topical CHG is regarded as a potent and durable disinfectant. Compared to no-rinse cloths, homemade rinse formulations have performed insufficiently.

To maximize their benefits, wipes can be saturated or loaded with creams or chemicals. To ensure proper saturation or coating of nonwoven wipes, suppliers of chlorhexidine gluconate wipes collaborate with formulation experts to create methods like gels, water-based solutions, waxes, and lotions. The goal is to create wipes that have the best texture, performance, and user experience. It is important for wipes to be presented in various folding arrangements, such as interfolded and z-folded stacks.

“Increased Eco-friendliness and High Sanitation Efficiency of Disinfectant Wipes”

With an increase in the incidence of hospital-acquired infections (HAIs), people are becoming more mindful of the significance of using disinfectants to prevent the spread of diseases.

Disinfectant wipes provide a quick and practical solution to clean and sanitize surfaces. With people leading busier lives, demand for practical and time-saving cleaning solutions is on the rise. Disinfectant wipes have become increasingly popular since they offer an efficient way to clean surfaces, particularly for individuals who have a hectic schedule.

As people become increasingly aware of the negative impact of chemicals, there is a growing trend towards natural and environmentally friendly products. This shift has also led to the rising popularity of natural and eco-friendly disinfecting wipes, which are considered safe and environmentally friendly.

What are the Hindrances to the Adoption of CHG Wipes?

“Stringent Governmental Regulations Governing Efficacy of Disinfectant Wipes”

The production of disinfection wipes is regulated by stringent guidelines set by various governmental bodies, which focus on product effectiveness and quality. It is thus difficult for new entrants to join the industry.

Although the chlorhexidine gluconate wipes market is highly fragmented with numerous small and medium-sized companies, the expansion of the market is threatened by regional competitors offering low-priced products.

“Rising Costs of Raw Materials Used in Production of CHG Wipes”

The production of disinfection wipes involves the use of cellulose, alcohol, and quaternary ammonium compounds as the primary ingredients. In recent years, the cost of these essential resources has risen, causing concerns among market participants.

Chlorhexidine gluconate wipes face competition from a variety of products available on the market, such as bleach, hydrogen peroxide, and alcohol-based sanitizers, which can be used as substitutes. Demand for chlorhexidine gluconate wipes is projected to grow because of heightened awareness of the benefits of using 2% chlorhexidine gluconate cloths for sanitization and an increase in the incidence of surgical site infections.

Country-wise Analysis

What are the Factors Driving the Demand for Chlorhexidine Gluconate Wipes in the United States?

“Increasing Hospital Admissions for Surgeries Fueling Demand for Chlorhexidine Gluconate Wipes”

North America accounts for a leading share of more than one-third of the global chlorhexidine gluconate wipes market because of a surge in surgical procedures, presence of major market players, increase in healthcare investments, and a growing aging population.

Chlorhexidine gluconate wipes are widely used in the United States as a potent and durable disinfectant to reduce the risk of infection during surgical procedures or for daily personal hygiene. Sales of chlorhexidine gluconate wipes have been growing steadily in recent years, driven by the increasing need to reduce hospital-acquired infections as identified by healthcare professionals.

• In April 2019, BD (Becton, Dickinson, and Company), a prominent global medical technology company, received FDA approval for its BD ChloraPrep skin preparation with sterile solution, which is the sole fully sterile chlorhexidine gluconate antibacterial skin preparation commercially available in the United States.

Why is Germany a Lucrative Market for Manufacturers of Chlorhexidine Gluconate Wipes?

“Expanding Geriatric Population Requiring Surgeries, Pushing Sales of CHG Wipes”

Sales of chlorhexidine gluconate wipes in Europe have been increasing as a result of the high healthcare expenditures in the region. Due to an increase in the geriatric population, Europe is also anticipated to hold a sizable share of the chlorhexidine gluconate wipes market.

Germany is a leading market for chlorhexidine gluconate wipes in Europe, driven by the increasing awareness of the importance of infection prevention and control in healthcare settings.

The preference for CHG wipes over other disinfectant wipes is rising due to their superior antimicrobial efficacy and long-lasting protection. The increasing use of chlorhexidine gluconate wipes in the homecare sector and the growing availability of CHG wipes on online platforms have also contributed to the growth of the market.

Why is Demand for CHG Wipes Growing in Australia?

"Rising Availability of Chlorhexidine Gluconate Wipes on Online Platforms"

In 2023, Australia accounts for 16.7% share of the Asia Pacific CHG wipes market.

Sales of chlorhexidine gluconate wipes in Australia are expected to grow due to increasing awareness about infection control and prevention in healthcare and personal hygiene settings. Rising prevalence of chronic diseases and surgical procedures has also led to an increase in demand for CHG wipes in the country.

Availability of a wide range of CHG wipes on various online platforms has made them easily accessible to consumers, contributing to the growth of the market.

Category-wise Analysis

Why Do Hospitals and Retail Pharmacies Account for High Sales of Chlorhexidine Gluconate Wipes?

"Increasing Risk of Hospital-acquired Infections Driving Up Sales of CHG Wipes”

Manufacturers of disinfectant wipes primarily focus on hospitals due to the heightened risk of hospital-acquired infections (HAIs) in these settings.

CHG wipes are also widely available for purchase at retail pharmacies, although their availability may vary depending on the specific pharmacy. Retail pharmacies may carry CHG wipes as an over-the-counter product for consumers to use at home for personal hygiene or wound care.

Why are Alcohol-based Chlorhexidine Gluconate Wipes Used Before Medical Procedures?

“High Efficacy of Alcohol-based Chlorhexidine Gluconate Wipes in Healthcare Settings”

Alcohol-based CHG wipes are disposable, pre-moistened wipes that are designed to be used for skin preparation before medical procedures, such as injections, blood draws, and minor surgical procedures.

These wipes contain a solution of isopropyl alcohol chlorhexidine gluconate, which work together to effectively clean and disinfect the skin. The alcohol evaporates rapidly from the skin, while the chlorhexidine gluconate offers prolonged antimicrobial action that remains effective for several hours following application.

Competitive Landscape

Manufacturers of chlorhexidine gluconate wipes primarily employ strategies such as technology launches, acquisitions, and R&D operations to improve their product offerings. To expand their product catalog of skin antiseptic wipes, these companies employ tactics such as new authorizations, launches, business growth, and acquisitions. Market participants in this area include 3M, Ecolab, BD, Afton Pharma, Basic Pharma Life Science Pvt. Ltd., and H&R Healthcare Ltd.

• Medline launched the ReadyPrep CHG pre-op skin antiseptic wipes with a chlorhexidine gluconate dose in February 2019. Chlorhexidine gluconate, an antiseptic known for its capacity to eliminate infection-causing bacteria from the skin, is pre-saturated in ReadyPrep CHG cloth at a 2% concentration.

Key Segments of Chlorhexidine Gluconate Wipes Industry

• By Type :

  • CHG Bath Wipes
  • CHG Alcohol-based Wipes

• By Application :

  • Surgical Site Infections
  • Central Line-associated Bloodstream Infections
  • Catheter-associated Urinary Tract Infections
  • Lens Cleansers

• By Concentration :

  • 2%
  • 5%

• By Distribution Channel :

  • Hospitals & Retail Pharmacies
  • Online Platforms

• By Region :

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa